S. Yessentayeva

S. Yessentayeva

Auto-generated profile, based on publicly available information

S. Yessentayeva

Kazakh-Russian Medical University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2025 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Open access
PDF file
DAD. Aidarov
D. Aidarov
SYS. Yesentaeva
S. Yesentaeva
Saken KhaidarovSaken Khaidarov
Saken Khaidarov
SOSaniya Ossikbayeva
Saniya Ossikbayeva
AAA. Aidarovа
A. Aidarovа
Relevance: Breast cancer (BC) ranks first in terms of prevalence among all malignant neoplasms in women in the Republic of Kazakhstan. Over the period 2015-2024, there has been a steady increase in the incidence, with the disease increasingly being detected in older women. Despite ongoing screening programs, breast cancer remains a significant cause of cancer mortality. For the first time, a comprehensive 10-year analysis of national breast cancer data was conducted with an assessment of the dynamics of morbidity, mortality, stage, and five-year survival. The study aimed to analyze changes in the incidence, mortality, survival, and stage of BC in women in the RK from 2015 to 2024 to assess the effectiveness of measures for early detection and treatment of the disease. Methods: The BC incidence and mortality analysis for 2015-2024 was based on official statistical reports (forms №7 and №090/U) and data from the national cancer registry. Demographic indicators were obtained from open sources of the Agency for Strategic Planning and Reforms of the Republic of Kazakhstan. Statistical processing was performed using SPSS software (version 23.0) with descriptive statistical methods, including calculating the means, confidence intervals, and trend rates. Results: During the study period, the incidence rate of BC increased from 45,7 to 47,6 per 100,000 women, while mortality declined from 14,2 to 7,8. Five-year survival rose by 81%, from 16,740 to 30,267 patients. The proportion of early-stage diagnoses (I-II) increased from 81,5% to 88,7%, and stage III cases nearly halved. The highest incidence was recorded in the 65-69 age group. A link has been established between screening coverage and mortality reduction. The results obtained refine and expand the previously presented regional data and can serve as a basis for improving preventive programs and improving the effectiveness of cancer care. Conclusion: Kazakhstan demonstrates a steady rise in BC incidence alongside a reduction in mortality and improvements in early diagnosis. These trends affirm the effectiveness of screening programs and oncologic care, although the stable rate of stage IV diagnoses highlights the need to eliminate barriers to timely medical consultation.

30 September 2022 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Closed access
VMV. Makarov
V. Makarov
DKD. Kaidarova
D. Kaidarova
SYS. Yessentayeva
S. Yessentayeva
JKJ. Kalmatayeva
J. Kalmatayeva
Madina MansurovaMadina Mansurova
Madina Mansurova
INI. Novikov
I. Novikov
Relevance: The 5-year overall survival rate(s) in NSCLC p-stage IA is 73%, and the recurrence rate in radically treated patients is almost 10%. The study aimed to evaluate the prognostic significance of several clinical and morphological factors and apply machine learning algorithms to predict the results of the overall survival of patients with lung cancer. Methods: The forms 030-6/y C34 – lung cancer (n=19,379) from the EROB database for 2014-2018 were analyzed, and the impact of risk factors on overall survival was assessed using the Kaplan-Meier method. Accordingly, the training data set for constructing forecasting models included 19,379 observations and 15 factors. The machine learning algorithms such as Random Forest Classifier, Gradient Boosting Classifier, Logistic Regression Model, Decision Tree Classifier, and K Nearest Neighbors (KNN) Classifier were implemented in the Python programming language. The results were evaluated by constructing an error matrix and calculating classification metrics: the proportion of correctly classified objects (accuracy) during training and validation (validation), accuracy (precision), completeness (recall), Kappa-Cohen. Results: In our study, 19,379 patients were analyzed, including 15,494 men (79.95%) and 3,885 women (20.04%). At the time of the study, 6,171 men (39.8%) and 1,962 women (49.5%) were alive. Median survival was 8.3 months (SE – 0.154 months, 95% CI – 7.96-8.56) in men and 15.43 months (SE – 1.0 months, 95% CI – 13.497-17.363) in women. At diagnosis, 1,037 patients (5.35%) had stage I disease, and 4,145 (21.38%) had stage II. Most patients (61.4%) had advanced stage NSCLC: 9,189 people (47.4%) were diagnosed with stage III, and 4,655 (24%) – with stage IV. The reliability of differences in median survival (χ2=3991.6, p=0.00) indicated the prognostic significance of the tumor process stage and its influence on the patient’s survival. Also, the revealed significant difference in the median survival of patients with various morphological forms of lung cancer suggests the prognostic significance of the morphological factor (the difference between those indicators was statistically significant, χ2=623.4 p=0.000). Conclusion: Machine learning models can predict the risk of fatal outcomes for patients after surgical treatment and registration in the EROB database. The creation of patient-oriented systems to support medical decision-making makes it possible to choose the optimal strategies for adjuvant therapy, dispensary observation, and frequency of diagnostic studies.

30 September 2022 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Closed access
VMV. Makarov
V. Makarov
DKD. Kaidarova
D. Kaidarova
SYS. Yessentayeva
S. Yessentayeva
JKJ. Kalmatayeva
J. Kalmatayeva
Madina MansurovaMadina Mansurova
Madina Mansurova
INI. Novikov
I. Novikov
Relevance: The 5-year overall survival rate(s) in NSCLC p-stage IA is 73%, and the recurrence rate in radically treated patients is almost 10%. The study aimed to evaluate the prognostic significance of several clinical and morphological factors and apply machine learning algorithms to predict the results of overall survival of patients with lung cancer. Methods: The forms 030-6/y C34 – lung cancer (n=19,379) from the EROB database for 2014-2018 were analyzed, and the impact of risk factors on overall survival was assessed using the Kaplan-Meier method. Accordingly, the training data set for constructing forecasting models included 19,379 observations and 15 factors. The machine learning algorithms such as Random Forest Classifier, Gradient Boosting Classifier, Logistic Regression Model, Decision Tree Classifier, and K Nearest Neighbors (KNN) Classifier were implemented in the Python programming lan- guage. The results were evaluated by constructing an error matrix, calculating classification metrics: the proportion of correctly classified objects (accuracy) during training and validation (validation), accuracy (precision), completeness (recall), Kappa-Cohen. Results: In our study, 19,379 patients were analyzed, including 15,494 men (79.95%) and 3,885 women (20.04%). At the time of the study, 6,171 men (39.8%) and 1,962 women (49.5%) were alive. Median survival was 8.3 months (SE – 0.154 months, 95% CI – 7.96-8.56) in men and 15.43 months (SE – 1.0 months, 95% CI – 13.497-17.363) in women. At diagnosis, 1,037 patients (5.35%) had stage I disease, other 4,145 (21.38%) had stage II. Most patients (61.4%) had advanced stage NSCLC: 9,189 people (47.4%) were diagnosed with stage III, and 4,655 (24%) – with stage IV. The reliability of differences in median survival (χ2=3991.6, p=0.00) indicated the prognostic significance of the tumor process stage and its influence on the patient’s survival. Also, the revealed significant difference in the median survival of patients with various morphological forms of lung cancer sug- gests the prognostic significance of the morphological factor (the difference between those indicators was statistically significant, χ2=623.4 p=0.000). Conclusion: Machine learning models can predict the risk of fatal outcomes for patients after surgical treatment and registration in the EROB database. The creation of patient-oriented systems to support medical decision-making makes it possible to choose the optimal strategies for adju- vant therapy, dispensary observation, and frequency of diagnostic studies